CVS Health said on Wednesday that it will split itself into two separate publicly traded companies by the first half of 2028, unwinding the vertically integrated healthcare conglomerate it spent years building. The move reverses the company's roughly $78 billion acquisition of insurer Aetna in 2018 and breaks up a business worth about $117 billion.
One company will keep the CVS Health name and hold the Aetna insurance unit, the Caremark pharmacy benefit manager, specialty pharmacies, and the Oak Street Health primary care clinics and Signify Health home-visit business. It will be run by current chief executive David Joyner. The second company, to be called CVS Pharmacy, will include the roughly 9,000 retail drugstores, the MinuteClinic chain, and the mail-order pharmacy business, led by group president Prem Shah. Existing shareholders will end up owning shares in both companies.
Shares closed down 12.5% at $79.96 on the day of the announcement, wiping nearly $15 billion off the company's market value. At the same time, CVS forecast 2027 adjusted earnings of at least $8.65 per share, ahead of analysts' estimates of $8.53. Chief financial officer Brian Newman warned on a conference call of challenges next year for the pharmacy benefit business, including a government discount drug pricing program, a weaker selling season, and declining membership in health plans.
The breakup caps two years of underperformance at Aetna that had already pushed CVS to explore a split in 2024. Joyner, who took over as chief executive in October 2024, said the pharmacy, benefit manager, and insurance businesses had improved enough over the past two years to stand on their own. The drugstores have also faced payment pressures and competition from Amazon and other online pharmacies, while the Federal Trade Commission settled a case this summer restricting how Caremark does business with other pharmacies.
Why it matters
The CVS breakup is the clearest verdict yet on the great healthcare consolidation experiment of the past decade: owning the insurer, the middleman, and the drugstore under one roof did not produce the returns its architects promised. Vertical integration was supposed to coordinate care and squeeze out costs; instead, Aetna's losses dragged down the whole group, and the pharmacy business was left starved of investment while it fought a price war with online rivals.
For investors, the split is a bet that two focused companies are worth more than one sprawling one — a pattern repeated across corporate America this decade. But the new standalone pharmacy inherits the hardest job: nearly 9,000 stores competing with Amazon on price and convenience, with roughly $60.7 billion of group debt still to be divided between the two companies and open questions about the dividend and which company keeps the CVS ticker. The insurance company, meanwhile, must prove Aetna can compete as a standalone insurer without the cushion of a giant retail operation. The market's 12.5% selloff suggests investors are not yet convinced the arithmetic works.
Source: Reuters — CVS Health to split in two, separating pharmacy business from insurance (November 4, 2026). Summary rewritten by VCTRIA.
